The results for seven candidate genes—CCDC181, GCM2, ITPRIPL1, ENPP2, LOC643719, ZNF177 and ADCY4—were successfully validated by sequencing and stable detection in ccfDNA from the plasma of Taiwanese patients with breast cancer. This evidence concerns the gene GCM2 and breast carcinoma.